1. Induced Disease Models Products Membrane Transporter/Ion Channel Anti-infection
  2. Digestive System Disease Models Five Sense Organs Disease Models Sodium Channel Virus Protease
  3. Liver Disease Models
  4. Phenytoin

Phenytoin  (Synonyms: 5,5-Diphenylhydantoin)

Cat. No.: HY-B0448 Purity: 99.95%
Handling Instructions Technical Support

Phenytoin (5,5-Diphenylhydantoin) is a potent Voltage-gated Na+ channels (VGSCs) blocker. Phenytoin has antiepileptic activity and reduces breast tumour growth and metastasis in mice.

For research use only. We do not sell to patients.

CAS No. : 57-41-0

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
500 mg In-stock
1 g In-stock
5 g In-stock
10 g   Get quote  
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 6 publication(s) in Google Scholar

Other Forms of Phenytoin:

Top Publications Citing Use of Products

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    Phenytoin (Isoproterenol, ISO,  1 mg/kg, i.p.). The typical ECG recording showing that ageing increased susceptibility to ISO-induced arrhythmias using PES with PCL from 90 ms to 30 ms.

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    Histogram of the VT occurrence rate in young and old mice with or without treatment of Phenytoin (Isoproterenol, ISO, 1  mg/kg, i.p.) (∗∗P < 0.01 and ∗∗∗P < 0.001).

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    The typical APD80 map and AP trace (young: black line; old: red line) in intact Langendorff perfused young and old mouse hearts before and following Phenytoin (Isoproterenol, ISO,  1μM) challenge in pacing at 10 Hz.

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    Quantitative analysis of APD80 from individual hearts in young and old mice before and following Phenytoin (Isoproterenol, ISO,  1μM) (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    Ageing induced fractional increases in APD80 challenged by Phenytoin (Isoproterenol, ISO,  1μM) (ΔAPD80) (P > 0.05).

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    The typical CaTD50 map and calcium transient trace (young: black line; old: red line) in intact Langendorff perfused young and old mouse hearts before and following Phenytoin (Isoproterenol, ISO,  1μM) challenge in pacing at 10 Hz.

    Phenytoin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 28;2022:8538296.  [Abstract]

    Histogram showing the τ30–90 in young and old mice before and following Phenytoin (Isoproterenol, ISO,  1μM) pacing at 10 Hz (∗P < 0.05 and ∗∗P < 0.01). n = 5 (each group).
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Phenytoin (5,5-Diphenylhydantoin) is a potent Voltage-gated Na+ channels (VGSCs) blocker. Phenytoin has antiepileptic activity and reduces breast tumour growth and metastasis in mice[1][2].

    Cellular Effect
    Cell Line Type Value Description References
    CHO IC50
    21.9 μM
    Compound: phenytoin
    Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits
    Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits
    [PMID: 23812503]
    HEK293 IC50
    125 μM
    Compound: Phenytoin
    Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit
    Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit
    [PMID: 22761000]
    HEK293 IC50
    49000 nM
    Compound: Phenytoin
    Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA
    Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA
    [PMID: 21300721]
    HEK293 IC50
    > 100 μM
    Compound: 24
    Inhibition of human Nav1.2 channel expressed in HEK cells by patch-clamp electrophysiology method
    Inhibition of human Nav1.2 channel expressed in HEK cells by patch-clamp electrophysiology method
    [PMID: 19394229]
    HEK293 IC50
    > 100 μM
    Compound: DPH
    Inhibition of human voltage-gated sodium channel 1.5 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis
    Inhibition of human voltage-gated sodium channel 1.5 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis
    [PMID: 22364743]
    HEK293 IC50
    > 100 μM
    Compound: DPH
    Inhibition of human voltage-gated sodium channel 1.7 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis
    Inhibition of human voltage-gated sodium channel 1.7 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis
    [PMID: 22364743]
    HEK293 IC50
    > 100 μM
    Compound: phenytoin
    Inhibition of human NaV1.2 expressed in HEK cells at -60 mV holding potential by patch clamp recording technique
    Inhibition of human NaV1.2 expressed in HEK cells at -60 mV holding potential by patch clamp recording technique
    [PMID: 20943396]
    HT-29 EC50
    500 μM
    Compound: 91
    Anti-necroptic activity in TNF alpha induced cell death in human HT-29 cells preincubated for 1 hr with compound and measured after 15 hrs in presence of TNFalpha/zVAD
    Anti-necroptic activity in TNF alpha induced cell death in human HT-29 cells preincubated for 1 hr with compound and measured after 15 hrs in presence of TNFalpha/zVAD
    [PMID: 36346971]
    L929 EC50
    500 μM
    Compound: 91
    Anti-necroptic activity in mouse L929 cells incubated for 2 hrs in presence of TNF/vVAD-fmk
    Anti-necroptic activity in mouse L929 cells incubated for 2 hrs in presence of TNF/vVAD-fmk
    [PMID: 36346971]
    Oocyte IC50
    9.8 μM
    Compound: 5
    Inhibition of human aquaporin 4 M23 isoform expressed in Xenopus laevis oocytes
    Inhibition of human aquaporin 4 M23 isoform expressed in Xenopus laevis oocytes
    [PMID: 18178093]
    Ventricular myocyte IC50
    103 μM
    Compound: Phenytoin
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    [PMID: 22761000]
    Ventricular myocyte IC50
    103000 nM
    Compound: Phenytoin
    Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes
    Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes
    [PMID: 21300721]
    In Vitro

    Phenytoin is an antiepileptic drug. It is useful to partial seizures and generalized tonic-clonic seizures but not primary generalized seizures such as absence seizures or myoclonic seizures. Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage-gated sodium channels[2].
    Phenytoin has low affinity for resting sodium channels at hyperpolarized membrane potentials[3].
    When neurons are depolarized and the channels transition into the open and inactivated states, greater binding and block occur. The inhibitory potency is strongly use dependent, so that block accumulates with prolonged or repetitive activation, such as occurs during a seizure discharge. The blocking of sodium channels by phenytoin is of slow onset. The time course of fast sodium currents is therefore not altered in the presence of the drug and action potentials evoked by synaptic depolarizations of ordinary duration are not blocked. Thus phenytoin is able to selectively inhibit pathological hyperexcitability in epilepsy without unduly impairing ongoing activity. Phenytoin also blocks persistent sodium current and this may be of particular importance in seizure control. Phenytoin is a class 1b antiarrhythmic[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Note:
    Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

    Phenytoin (60 mg/kg; once daily for 28 days) sodium reduces MDA-MB-231 cells in six-week-old female Rag2-/- Il2rg-/- mice[1].
    Phenytoin can induce a model of gingival hyperplasia in mice[6].

    Induction of Gingival Hyperplasia in Mice[5]
    Background
    Phenytoin induced gingival overgrowth, a side effect with multifactorial aetiology, is characterized by an increase in the volume of extracellular tissues, particularly collagenous components, with varying degrees of inflammation.
    Specific Modeling Methods
    Mice: BALB/cByJ • male • 8 week old
    Administration: 30 mg/kg • miniosmotic pumps • 0.5-μL/h • 2 weeks
    Note
    (1) Mice are housed for 1 week before any procedure for acclimation.
    (2) Pumps are replaced every 2 weeks throughout the 12-week experimental period.
    (3) Mice are then euthanized and heads are immediately placed in freshly made 4% paraformaldehyde for 24 hours for fixation.
    Modeling Indicators
    Morphology: Gingival overgrowth was apparent in the maxillary anterior gingival tissue of mice; Increased the papillary height and area.
    Histomorphometry: Increased epithelial thickness and area in the maxillary anterior zone.
    Molecular changes: Ccn2 is overexpressed in all regions of the epithelium; TGF-β1 and LOXL2 is overexpressed in both epithelial and connective tissues.
    Correlated Product(s): Cyclosporine A (HY-B0579)
    Opposite Product(s): Lovastatin (HY-N0504)

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    252.27

    Formula

    C15H12N2O2

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C1NC(C(C2=CC=CC=C2)(C3=CC=CC=C3)N1)=O

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : 50 mg/mL (198.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.9640 mL 19.8200 mL 39.6401 mL
    5 mM 0.7928 mL 3.9640 mL 7.9280 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (9.91 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (9.91 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.95%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.9640 mL 19.8200 mL 39.6401 mL 99.1002 mL
    5 mM 0.7928 mL 3.9640 mL 7.9280 mL 19.8200 mL
    10 mM 0.3964 mL 1.9820 mL 3.9640 mL 9.9100 mL
    15 mM 0.2643 mL 1.3213 mL 2.6427 mL 6.6067 mL
    20 mM 0.1982 mL 0.9910 mL 1.9820 mL 4.9550 mL
    25 mM 0.1586 mL 0.7928 mL 1.5856 mL 3.9640 mL
    30 mM 0.1321 mL 0.6607 mL 1.3213 mL 3.3033 mL
    40 mM 0.0991 mL 0.4955 mL 0.9910 mL 2.4775 mL
    50 mM 0.0793 mL 0.3964 mL 0.7928 mL 1.9820 mL
    60 mM 0.0661 mL 0.3303 mL 0.6607 mL 1.6517 mL
    80 mM 0.0496 mL 0.2478 mL 0.4955 mL 1.2388 mL
    100 mM 0.0396 mL 0.1982 mL 0.3964 mL 0.9910 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Phenytoin
    Cat. No.:
    HY-B0448
    Quantity:
    MCE Japan Authorized Agent: